title: Upregulation of the axonal growth and the expression of substance P and its NK1 receptor in human allergic contact dermatitis.
abstract: Nerve fibers and sensory neuropeptides substance P and calcitonin gene-related peptide (CGRP) have been reported to be involved in allergic contact dermatitis (ACD). In the present study, we investigated the general innervation (using antibody against protein gene product 9.5, PGP 9.5), axonal growth (using antibody against growth associated protein, GAP-43), CGRP, and substance P with its receptor neurokinin 1 (NK1), in positive epicutaneous reactions to nickel sulphate from nickel-allergic patients, at the peak of inflammation, 72 hr after challenge with the antigen. There was an increased (p < 0.01) number of GAP-43 positive fibers in the eczematous compared with control skin, indicating an increased axonal growth already at 72 hr postchallenge. Double staining revealed a coexpression of CGRP and GAP-43 on dermal nerve fibers. There was no difference in the number of substance P and CGRP positive nerve fibers between eczematous and control skin. However, semiquantification analyses showed an increased expression of substance P positive inflammatory cells, being CD3, CD4, or CD8 positive, and NK1R positive inflammatory cells, being tryptase or CD3 positive. These results indicate a contribution of regenerating nerve fibers and substance P to the contact allergic reaction.
authors.affiliation: Unit of Dermatology and Venereology, Department of Medicine, Karolinska University Hospital, Solna, Stockholm, Sweden. Husameldine.elnour@ki.se
authors.forename: H
authors.initials: H
authors.lastname: El-Nour
authors.forename: L
authors.initials: L
authors.lastname: Lundeberg
authors.forename: R
authors.initials: R
authors.lastname: Al-Tawil
authors.forename: A
authors.initials: A
authors.lastname: Granlund
authors.forename: S-B
authors.initials: SB
authors.lastname: Lonne-Rahm
authors.forename: K
authors.initials: K
authors.lastname: Nordlind
mesh_terms: D001369:Axons / Q000502:physiology*; D015740:Calcitonin Gene-Related Peptide / Q000096:biosynthesis; D017449:Dermatitis, Allergic Contact / Q000378:metabolism* / Q000503:physiopathology*; D019922:GAP-43 Protein / Q000096:biosynthesis; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation / Q000473:pathology; D008856:Microscopy, Fluorescence; D018040:Receptors, Neurokinin-1 / Q000096:biosynthesis*; D012867:Skin / Q000473:pathology; D012882:Skin Tests; D013373:Substance P / Q000096:biosynthesis*; D053802:Tryptases / Q000096:biosynthesis; D043222:Ubiquitin Thiolesterase / Q000096:biosynthesis; D015854:Up-Regulation / Q000502:physiology*
chemical_list: D019922:GAP-43 Protein; D018040:Receptors, Neurokinin-1; C482860:UCHL1 protein, human; D013373:Substance P; D043222:Ubiquitin Thiolesterase; D053802:Tryptases; D015740:Calcitonin Gene-Related Peptide